Phase III Study of ISU302 in Patients With Type 1 Gaucher Disease
A Multicenter, Open-Label Phase III Study to Evaluate the Safety and Efficacy of ISU302 (Imiglucerase for Injection) in Patients With Type 1 Gaucher Disease A Multicenter, Open-Label Phase III Study to Evaluate the Safety and Efficacy of ISU302(Imiglucerase ...
The Safety and Efficacy Study of ISU302 in Patient With Type I Gaucher Disease
A Multi-national Randomized Double Blinded Phase III Study to Evaluate the Safety and Efficacy of ISU302(Imiglucerase for Injection) or Cerezyme in Patient With Type I Gaucher Disease A Multi-national Randomized Double Blinded Phase III Study to Evaluate the Safety and Efficacy of IS ...
A Study of the Tolerability, Safety, and Pharmacokinetics of ISU302 in Healthy Volunteers
A Dose Block-randomized, Double-blind, Placebo-controlled, Single Dosing, Dose-escalation Phase I Clinical Trial to Evaluate the Tolerability, Safety, and Pharmacokinetics of ISU302 in Healthy Volunteers A Dose Block-randomized, Double-blind, Placebo-controlled, Single Dosing, Dose-escalation Phase I Cl ...